Literature DB >> 27769112

Quantitative Proteomics Illuminates a Functional Interaction between mDia2 and the Proteasome.

Tadamoto Isogai, Rob van der Kammen, Onno B Bleijerveld, Soenita S Goerdayal1, Elisabetta Argenzio, A F Maarten Altelaar1,2, Metello Innocenti.   

Abstract

Formin mDia2 is a cytoskeleton-regulatory protein that switches reversibly between a closed, autoinhibited and an open, active conformation. Although the open conformation of mDia2 induces actin assembly thereby controlling many cellular processes, mDia2 possesses also actin-independent and conformation-insensitive scaffolding roles related to microtubules and p53, respectively. Thus, we hypothesize that mDia2 may have other unappreciated functions and regulatory modes. Here we identify and validate proteasome and Ubiquitin as mDia2-interacting partners using stable isotope labeling with amino acids in cell culture-based quantitative proteomics and biochemistry, respectively. Although mDia2 is ubiquitinated, binds ubiquitinated proteins and free Ubiquitin, it is not a proteasome substrate. Surprisingly, knockdown of mDia2 increases the activity of the proteasome in vitro, whereas mDia2 overexpression has opposite effects only when it adopts the open conformation and cannot induce actin assembly. Consistently, a combination of candidate and unbiased proteome-wide analyses indicates that mDia2 regulates the cellular levels of proteasome substrate β-catenin and a number of ubiquitinated actin-regulatory proteins. Hence, these findings add more complexity to the mDia2 activity cycle by showing that the open conformation may control actin dynamics also through actin-independent regulation of the proteasome.

Entities:  

Keywords:  Formin; SILAC; affinity purification; biochemistry; mass spectrometry; quantitative proteomics

Mesh:

Substances:

Year:  2016        PMID: 27769112     DOI: 10.1021/acs.jproteome.6b00718

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

Review 1.  New insights into the formation and the function of lamellipodia and ruffles in mesenchymal cell migration.

Authors:  Metello Innocenti
Journal:  Cell Adh Migr       Date:  2018-05-08       Impact factor: 3.405

2.  A Protumorigenic mDia2-MIRO1 Axis Controls Mitochondrial Positioning and Function in Cancer-Associated Fibroblasts.

Authors:  Michael Cangkrama; Huan Liu; James Whipman; Maria Zubair; Mai Matsushita; Michela Di Filippo; Manfred Kopf; Metello Innocenti; Sabine Werner
Journal:  Cancer Res       Date:  2022-10-17       Impact factor: 13.312

3.  Initiation of DNA replication requires actin dynamics and formin activity.

Authors:  Nikolaos Parisis; Liliana Krasinska; Bethany Harker; Serge Urbach; Michel Rossignol; Alain Camasses; James Dewar; Nathalie Morin; Daniel Fisher
Journal:  EMBO J       Date:  2017-10-05       Impact factor: 11.598

4.  Flat clathrin lattices are dynamic actin-controlled hubs for clathrin-mediated endocytosis and signalling of specific receptors.

Authors:  Daniela Leyton-Puig; Tadamoto Isogai; Elisabetta Argenzio; Bram van den Broek; Jeffrey Klarenbeek; Hans Janssen; Kees Jalink; Metello Innocenti
Journal:  Nat Commun       Date:  2017-07-13       Impact factor: 14.919

5.  Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).

Authors:  Kaitlyn M Dvorak; Krista M Pettee; Kaitlin Rubinic-Minotti; Robin Su; Andrea Nestor-Kalinoski; Kathryn M Eisenmann
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

6.  Profilin binding couples chloride intracellular channel protein CLIC4 to RhoA-mDia2 signaling and filopodium formation.

Authors:  Elisabetta Argenzio; Jeffrey Klarenbeek; Katarzyna M Kedziora; Leila Nahidiazar; Tadamoto Isogai; Anastassis Perrakis; Kees Jalink; Wouter H Moolenaar; Metello Innocenti
Journal:  J Biol Chem       Date:  2018-10-31       Impact factor: 5.157

7.  A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming.

Authors:  Michael Cangkrama; Mateusz Wietecha; Nicolas Mathis; Rin Okumura; Luca Ferrarese; Dunja Al-Nuaimi; Maria Antsiferova; Reinhard Dummer; Metello Innocenti; Sabine Werner
Journal:  EMBO Mol Med       Date:  2020-03-09       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.